Načítá se...
Targeting CD44 Augments the Efficacy of Tregs in Autoimmune Diabetes
Curing type 1 diabetes (T1D) will require lasting control of the autoimmune response that destroys insulin-producing islet β-cells. Re-establishing tolerance by restoring/replacing Tregs has significant potential for treatment of T1D but will require strategies to augment and maintain their efficacy...
Uloženo v:
| Vydáno v: | Immunol Lett |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4323628/ https://ncbi.nlm.nih.gov/pubmed/25447401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.imlet.2014.10.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|